Homepage600535 • SHA
add
Tasly Pharmaceutical Group Co Ltd
Vorige slotkoers
¥ 15,36
Dag-range
¥ 15,31 - ¥ 15,49
Jaar-range
¥ 12,24 - ¥ 17,77
Beurswaarde
22,95 mld. CNY
Gem. volume
12,72 mln.
Koers/winst
23,65
Dividendrendement
3,44%
Primaire beurs
SHA
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(CNY) | dec 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 2,04 mld. | -3,19% |
Bedrijfskosten | 1,19 mld. | -7,47% |
Netto inkomsten | 113,38 mln. | 191,83% |
Netto winstmarge | 5,57 | 201,08% |
Winst per aandeel | — | — |
EBITDA | 284,03 mln. | 18,49% |
Effectief belastingtarief | 57,14% | — |
Balans
Totale activa
Totale passiva
(CNY) | dec 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 3,52 mld. | -25,95% |
Totale activa | 14,98 mld. | -10,40% |
Totale passiva | 2,87 mld. | -28,80% |
Totaal aandelenvermogen | 12,11 mld. | — |
Uitstaande aandelen | 1,49 mld. | — |
Koers-boekwaardeverhouding | 1,93 | — |
Rendement op activa | 2,91% | — |
Rendement op kapitaal | 3,19% | — |
Kasstroom
Nettomutatie in liquide middelen
(CNY) | dec 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 113,38 mln. | 191,83% |
Operationele kasstroom | 824,63 mln. | -44,51% |
Kasstroom uit beleggingen | 558,23 mln. | 130,84% |
Kasstroom uit financiering | -1,59 mld. | -52,86% |
Nettomutatie in liquide middelen | -203,28 mln. | 85,09% |
Vrije kasstroom | 243,38 mln. | -77,61% |
Over
Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines.
It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange.
In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation.
In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife. Wikipedia
Opgericht
1994
Website
Werknemers
10.958